NCT00042991View on ClinicalTrials.gov

Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

February 28, 2010

Study Completion Date

March 31, 2010

Conditions

Untreated Childhood Anaplastic AstrocytomaUntreated Childhood Anaplastic OligodendrogliomaUntreated Childhood Brain Stem GliomaUntreated Childhood Giant Cell GlioblastomaUntreated Childhood GlioblastomaUntreated Childhood Gliomatosis CerebriUntreated Childhood GliosarcomaUntreated Childhood Oligodendroglioma

Interventions

DRUG

gefitinib

Given orally

RADIATION

radiation therapy

Undergo standard brain irradiation

OTHER

pharmacological study

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

38105

Pediatric Brain Tumor Consortium, Memphis

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00042991 - Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas | Biotech Hunter | Biotech Hunter